Clinical Features and Predictors of a Complicated Treatment Course in Peripheral Tuberculous Lymphadenitis
Open accessThe DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
Background/purpose There remains uncertainty regarding the treatment strategy for patients with peripheral tuberculous lymphadenitis (pTBL) in areas endemic for tuberculosis. The purpose of this study was to demonstrate the clinical features and assess the predictors of a complicated treatment course in pTBL.Methods A retrospective analysis of 97 pTBL patients from January 1995 through to December 2004 was conducted. Patient characteristics with and without a complicated treatment course, defined as prolonged treatment (>9 months) and/or relapse, were compared for determining the predictors.Results The disease occurred predominantly in females (57.7%) with a mean age of 37. Most patients (72%) were asymptomatic. Cervical nodes were the most common (72%) manifestations. Fifty-six patients completed a 6-9 month course of therapy without relapse; 28 had a prolonged but complete treatment course, and 13 relapsed within a mean of 8.5 months after treatment (range, 3-42 months; median, 7.8 months). Of 97 pTBL patients, six had enlarged or newly appeared lymph nodes during treatment. Multivariate analysis indicated that low body mass index and bilateral cervical nodes were independent determinants of a complicated treatment course with the odds ratios of 1.2 (95% CI, 1.01-1.41; p=0.042) and 3.9 (95% CI, 1.08-14.0; p=0.038), respectively.Conclusion This study found that pTBL is more likely to occur in young female patients. For patients who present with bilateral cervical nodes and low body mass index, a prolonged treatment course to ensure disease control should be considered.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Median lymph node size is 3 cm, but nodes may be up to 8-10 cm in diameter [15].”
From Current diagnosis and management of peripheral tuberculous lymphadenitis. (2011) · cites this paper as [15]
In the citing paper
“Cervical chain involvement is most common and is reported in 45%-70% of cases”
From Current diagnosis and management of peripheral tuberculous lymphadenitis. (2011) · cites this paper as [15]
In the citing paper
“Patients do not generally report significant pain at presentation, and node tenderness during examination is noted in only 10%-35% of cases [3, 15, 17].”
From Current diagnosis and management of peripheral tuberculous lymphadenitis. (2011) · cites this paper as [15]
In the citing paper
“Systemic symptoms are reported more frequently in HIV-positive patients than in HIV-negative patients (76% of 21 vs 12% of 43 in a report from Taiwan) [15].”
From Current diagnosis and management of peripheral tuberculous lymphadenitis. (2011) · cites this paper as [15]
Citations
Cites
The Growing Burden of Tuberculosis: Global Trends and Interactions With the HIV Epidemic
Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C., & Dye, C. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1009 · Cited by 2,553
(2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.167.4.603 · Cited by 1,944
Peripheral lymph node tuberculosis: A review of 80 cases
Dandapat, M. C., Mishra, B. M., Dash, S. P., & Kar, P. K. (1990) · Journal of British Surgery · doi:10.1002/bjs.1800770823 · Cited by 315
Epidemiology of Extrapulmonary Tuberculosis
Mehta, J. B., Dutt, A., Harvill, L., & Mathews, K. M. (1991) · Chest · doi:10.1378/chest.99.5.1134 · Cited by 275
Hopewell, P. C. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.3.540 · Cited by 196
Incidence of pulmonary tuberculosis among diabetics
Kim, S. J., Hong, Y. P., Lew, W. J., Yang, S. C., & Lee, E. G. (1995) · Tubercle and Lung Disease · doi:10.1016/0962-8479(95)90529-4 · Cited by 181
Peripheral Tuberculous Lymphadenitis: Epidemiology, Diagnosis, Treatment, and Outcome
Polesky, A., Grove, W., & Bhatia, G. (2005) · Medicine · doi:10.1097/01.md.0000189090.52626.7a · Cited by 165
Assessment of Lymph Node Tuberculosis in Northern Germany
Geldmacher, H., Taube, C., Kroeger, C., Magnussen, H., & Kirsten, D. K. (2002) · Chest · doi:10.1378/chest.121.4.1177 · Cited by 162
Extra-pulmonary and pulmonary tuberculosis in Hong Kong.
Noertjojo, K., Tam, C. M., Chan, S. L., & Chan-Yeung, M. M. W. (2002) · PubMed · Cited by 132
Isolated Peripheral Tuberculous Lymphadenitis in Adults: Current Clinical and Diagnostic Issues
Artenstein, A. W., Kim, J. H., Williams, W. J., & Chung, R. C. Y. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.4.876 · Cited by 131 · cited 1×
“264 HIV positive 21/64 (33) 9/35 (26) 12/29 (41) Immunocompromised‡ 8/97 (8) 5/56 (9) 3/41 (7) 0.”
Cited by
Current diagnosis and management of peripheral tuberculous lymphadenitis.
Fontanilla, J.-M., Barnes, A., & von Reyn, C. F. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir454 · Cited by 299
Paradoxical responses in non-HIV-infected patients with peripheral lymph node tuberculosis
Cho, O.-H., Park, K.-H., Kim, T., Song, E. H., Jang, E.-Y., Lee, E. J., Chong, Y. P., Choi, S.-H., Lee, S.-O., Woo, J. H., et al. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.05.006 · Cited by 87
Prevalence of inappropriate tuberculosis treatment regimens: a systematic review
Langendam, M. W., van der Werf, M. J., Huitric, E., & Manissero, D. (2011) · European Respiratory Journal · doi:10.1183/09031936.00125511 · Cited by 41
Smaoui, S., Mezghanni, M. A., Hammami, B., Zalila, N., Marouane, C., Kammoun, S., Ghorbel, A., Jemâa, M. B., & Messadi-Akrout, F. (2015) · International Journal of Mycobacteriology · doi:10.1016/j.ijmyco.2015.04.004 · Cited by 38
Sarfaraz, S., Iftikhar, S., Memon, Y., Zahir, N., Hereker, F. F., & Salahuddin, N. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.08.020 · Cited by 35
Metadata
- Authors
- Wei, Y.-F., Liaw, Y.-S., Ku, S.-C., Chang, Y.-L., & Yang, P.-C.
- Affiliations
- E-Da Hospital (TW)
- National Taiwan University Hospital (TW)
- Venue
- Journal of the Formosan Medical Association
- Publisher
- Elsevier BV
- Published
- 2008-03
- Volume
- 107
- Issue
- 3
- Pages
- 225-231
- ISSN
- 0929-6646 (ISSN-L)
- OpenAlex
- W1970290330
- Cited by
- 32
- References
- 35
- Citations by year
- 2026: 1 · 2024: 4 · 2023: 5 · 2021: 1 · 2018: 5 · 2016: 1 · 2015: 3 · 2014: 3 · 2013: 1
- FWCI
- 2.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2887 d)
- Locations
- Journal of the Formosan Medical Association (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- American Thoracic Society
- National Taiwan University Hospital
- Topics
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphadenopathy Diagnosis and Analysis
- Keywords
- treatment relapse, low body mass index, tuberculosis treatment
- MeSH terms
- Adolescent, Adult, Aged, Child, Child, Preschool, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Retrospective Studies, Tuberculosis, Lymph Node, Body Mass Index, Multivariate Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Features and Predictors of a Complicated Treatment Course in Peripheral Tuberculous Lymphadenitis. https://app.cochat.ai/papers/10.1016/s0929-6646(08)60140-0
- The paper
- Wei, Y.-F., Liaw, Y.-S., Ku, S.-C., Chang, Y.-L., & Yang, P.-C. (2008). Clinical Features and Predictors of a Complicated Treatment Course in Peripheral Tuberculous Lymphadenitis. Journal of the Formosan Medical Association. https://doi.org/10.1016/s0929-6646(08)60140-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.